Week41, 2020
1. Influenza activity is minimal across the U.S., with 0.3% of respiratory specimens testing positive for influenza in clinical labs.
2. Of 26 positive specimens in clinical labs, 50% were Influenza A and 50% were Influenza B, with no subtyping details.
3. Public health labs reported no positive influenza specimens this week.
4. Influenza-like illness (ILI) accounted for 1.2% of outpatient visits, unchanged from last week and below the national baseline of 2.6%.
5. Pneumonia, influenza, or COVID-19 (PIC) contributed to 7.2% of deaths, exceeding the epidemic threshold of 5.7%.
6. No pediatric deaths have been reported for the 2020-21 season, but three influenza-associated pediatric deaths from the previous season were added retrospectively.
7. Hospitalization rates and virus characterization updates are postponed due to low influenza activity.
8. CDC encourages universal flu vaccination by the end of October; no notable vaccination data trends were mentioned.
9. Healthcare-seeking behavior patterns are altered by the COVID-19 pandemic, affecting traditional ILI surveillance reliability.
10. Flu activity remains uncertain, with ongoing monitoring of alternative care locations and COVID-19 trends influencing predictions.